Indivior plc (INDV) ORD USD0.5
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Indivior reports first-quarter growth, confirms plans to shift main listing
25 April 2024 08:56
(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed...
-
Indivior receives settlement approval for antitrust litigation
29 February 2024 09:47
(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.
-
London close: Stocks rise amid raft of solid earnings
22 February 2024 16:26
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
-
Indivior planning to move primary listing to US, shares surge
22 February 2024 08:26
(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.
-
London close: Stocks rise as UK inflation slows further
20 December 2023 15:05
(Sharecast News) - London's stock markets saw a notable upswing on Wednesday, driven by encouraging data revealing a greater-than-anticipated slowdown in UK inflation for November.
-
Indivior strikes agreement with Actavis over patent dispute
20 December 2023 07:26
(Sharecast News) - Indivior announced significant agreement in its ongoing patent dispute with Actavis Laboratories UT, a subsidiary of Teva Pharmaceuticals, on Wednesday.
-
London close: Stocks mixed ahead of Autumn Statement
20 November 2023 14:59
(Sharecast News) - London's stock markets saw a mixed performance at the close of trading on Monday, with Ashtead and Compass among the leading losers.
-
Indivior announces $100m share buyback
17 November 2023 12:15
(Sharecast News) - Pharma group Indivior has announced a $100m share buyback to reduce its issued shared capital and return cash to shareholders.
-
Indivior extends deal with investor Scopia to keep boardmember Jerome Lande
17 November 2023 07:56
(Sharecast News) - Pharma group Indivior has extended its deal with shareholder Scopia Capital Management that will see the latter's representative Jerome Lande stay on the board until the end of next...
-
London close: Stocks gain as investors await Powell speech
9 November 2023 15:02
(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair...
-
Indivior swings to loss despite strong Sublocade performance
9 November 2023 08:39
(Sharecast News) - Indivior reported a solid third-quarter financial performance on Thursday, as Sublocade net revenue jumped 55% year-on-year to $167m, although a significant cash outflow saw it swing to a...
-
London close: Stocks mixed at start of busy week
23 October 2023 19:21
(Sharecast News) - London's stock markets finished with a varied performance on Monday, driven by concerns over rising UK bond yields and global interest rate trends.
Company announcements Announcements
-
Block listing Interim Review
10 May 2024 10:05
Indivior
-
Board Committee Changes
10 May 2024 07:00
Indivior
-
Transaction in Own Shares
10 May 2024 07:00
Indivior
-
Result of AGM
9 May 2024 15:30
Indivior
-
Transaction in Own Shares
9 May 2024 07:00
Indivior
-
Transaction in Own Shares
8 May 2024 07:00
Indivior
-
Transaction in Own Shares
7 May 2024 07:00
Indivior
-
Publication of Notice of General Meeting
3 May 2024 14:12
Indivior
-
Transaction in Own Shares
3 May 2024 07:00
Indivior
-
Transaction in Own Shares
2 May 2024 07:00
Indivior
-
Total Voting Rights
1 May 2024 08:58
Indivior
-
Transaction in Own Shares
1 May 2024 07:00
Indivior
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.